Name | Number of supported studies | Average coverage | |
---|---|---|---|
natural killer cell | 7 studies | 20% ± 3% | |
astrocyte | 7 studies | 29% ± 11% | |
CD16-positive, CD56-dim natural killer cell, human | 6 studies | 18% ± 3% | |
endothelial cell | 5 studies | 28% ± 10% | |
mucosal invariant T cell | 5 studies | 19% ± 2% | |
glutamatergic neuron | 5 studies | 49% ± 21% | |
microglial cell | 4 studies | 23% ± 6% | |
CD16-negative, CD56-bright natural killer cell, human | 4 studies | 18% ± 1% | |
interneuron | 4 studies | 28% ± 13% | |
epithelial cell | 3 studies | 23% ± 5% | |
retinal cone cell | 3 studies | 21% ± 3% | |
GABAergic neuron | 3 studies | 43% ± 3% | |
macrophage | 3 studies | 26% ± 5% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 6 studies | 35% ± 18% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
lung | 100% | 2288.75 | 577 / 578 | 99% | 7.69 | 1142 / 1155 |
thymus | 100% | 2813.49 | 651 / 653 | 98% | 35.07 | 594 / 605 |
brain | 98% | 1373.38 | 2594 / 2642 | 99% | 12.68 | 701 / 705 |
breast | 100% | 2110.68 | 458 / 459 | 97% | 7.59 | 1080 / 1118 |
esophagus | 96% | 1721.42 | 1387 / 1445 | 99% | 7.20 | 182 / 183 |
intestine | 99% | 1644.16 | 958 / 966 | 92% | 4.34 | 484 / 527 |
uterus | 99% | 1500.63 | 169 / 170 | 90% | 5.83 | 413 / 459 |
stomach | 96% | 1240.07 | 344 / 359 | 93% | 4.63 | 267 / 286 |
ovary | 100% | 2636.84 | 180 / 180 | 88% | 4.39 | 380 / 430 |
pancreas | 91% | 883.09 | 300 / 328 | 96% | 5.77 | 170 / 178 |
kidney | 93% | 910.56 | 83 / 89 | 93% | 6.55 | 834 / 901 |
adrenal gland | 100% | 1809.78 | 258 / 258 | 84% | 5.12 | 193 / 230 |
skin | 100% | 2143.45 | 1809 / 1809 | 84% | 3.88 | 395 / 472 |
bladder | 100% | 1407.24 | 21 / 21 | 78% | 3.80 | 392 / 504 |
prostate | 98% | 1270.54 | 241 / 245 | 78% | 3.00 | 393 / 502 |
liver | 95% | 1557.39 | 215 / 226 | 81% | 4.89 | 330 / 406 |
spleen | 100% | 1852.29 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 8.02 | 45 / 45 |
adipose | 99% | 2110.97 | 1195 / 1204 | 0% | 0 | 0 / 0 |
peripheral blood | 97% | 1570.68 | 900 / 929 | 0% | 0 | 0 / 0 |
blood vessel | 97% | 1721.63 | 1290 / 1335 | 0% | 0 | 0 / 0 |
muscle | 96% | 2154.88 | 768 / 803 | 0% | 0 | 0 / 0 |
heart | 89% | 878.90 | 767 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 86% | 6.32 | 25 / 29 |
eye | 0% | 0 | 0 / 0 | 35% | 1.18 | 28 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0097009 | Biological process | energy homeostasis |
GO_0050796 | Biological process | regulation of insulin secretion |
GO_1901985 | Biological process | positive regulation of protein acetylation |
GO_2000074 | Biological process | regulation of type B pancreatic cell development |
GO_0007283 | Biological process | spermatogenesis |
GO_2000772 | Biological process | regulation of cellular senescence |
GO_0090263 | Biological process | positive regulation of canonical Wnt signaling pathway |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_2001016 | Biological process | positive regulation of skeletal muscle cell differentiation |
GO_0032007 | Biological process | negative regulation of TOR signaling |
GO_0045599 | Biological process | negative regulation of fat cell differentiation |
GO_2000323 | Biological process | negative regulation of glucocorticoid receptor signaling pathway |
GO_0032922 | Biological process | circadian regulation of gene expression |
GO_0007623 | Biological process | circadian rhythm |
GO_0090403 | Biological process | oxidative stress-induced premature senescence |
GO_0051775 | Biological process | response to redox state |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_0042753 | Biological process | positive regulation of circadian rhythm |
GO_0043161 | Biological process | proteasome-mediated ubiquitin-dependent protein catabolic process |
GO_0006355 | Biological process | regulation of DNA-templated transcription |
GO_0042634 | Biological process | regulation of hair cycle |
GO_0050767 | Biological process | regulation of neurogenesis |
GO_0045892 | Biological process | negative regulation of DNA-templated transcription |
GO_0051726 | Biological process | regulation of cell cycle |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0120163 | Biological process | negative regulation of cold-induced thermogenesis |
GO_0005654 | Cellular component | nucleoplasm |
GO_0033391 | Cellular component | chromatoid body |
GO_0016605 | Cellular component | PML body |
GO_0034751 | Cellular component | aryl hydrocarbon receptor complex |
GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
GO_1990513 | Cellular component | CLOCK-BMAL transcription complex |
GO_0000785 | Cellular component | chromatin |
GO_0005634 | Cellular component | nucleus |
GO_0003677 | Molecular function | DNA binding |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0140297 | Molecular function | DNA-binding transcription factor binding |
GO_0017162 | Molecular function | aryl hydrocarbon receptor binding |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO_0043565 | Molecular function | sequence-specific DNA binding |
GO_0051879 | Molecular function | Hsp90 protein binding |
GO_0000976 | Molecular function | transcription cis-regulatory region binding |
GO_1990837 | Molecular function | sequence-specific double-stranded DNA binding |
GO_0003712 | Molecular function | transcription coregulator activity |
GO_0070888 | Molecular function | E-box binding |
GO_0046983 | Molecular function | protein dimerization activity |
GO_0005515 | Molecular function | protein binding |
Gene name | BMAL1 |
Protein name | Basic helix-loop-helix ARNT-like protein 1 (Aryl hydrocarbon receptor nuclear translocator-like protein 1) (Basic-helix-loop-helix-PAS protein MOP3) (Brain and muscle ARNT-like 1) (Class E basic helix-loop-helix protein 5) (bHLHe5) (Member of PAS protein 3) (PAS domain-containing protein 3) (bHLH-PAS protein JAP3) Basic helix-loop-helix ARNT-like protein 1 (Aryl hydrocarbon receptor nuclear translocator-like protein 1) (Brain and muscle ARNT-like 1) Basic helix-loop-helix ARNT like 1 |
Synonyms | BHLHE5 MOP3 PASD3 ARNTL |
Description | FUNCTION: Transcriptional activator which forms a core component of the circadian clock. The circadian clock, an internal time-keeping system, regulates various physiological processes through the generation of approximately 24 hour circadian rhythms in gene expression, which are translated into rhythms in metabolism and behavior. It is derived from the Latin roots 'circa' (about) and 'diem' (day) and acts as an important regulator of a wide array of physiological functions including metabolism, sleep, body temperature, blood pressure, endocrine, immune, cardiovascular, and renal function. Consists of two major components: the central clock, residing in the suprachiasmatic nucleus (SCN) of the brain, and the peripheral clocks that are present in nearly every tissue and organ system. Both the central and peripheral clocks can be reset by environmental cues, also known as Zeitgebers (German for 'timegivers'). The predominant Zeitgeber for the central clock is light, which is sensed by retina and signals directly to the SCN. The central clock entrains the peripheral clocks through neuronal and hormonal signals, body temperature and feeding-related cues, aligning all clocks with the external light/dark cycle. Circadian rhythms allow an organism to achieve temporal homeostasis with its environment at the molecular level by regulating gene expression to create a peak of protein expression once every 24 hours to control when a particular physiological process is most active with respect to the solar day. Transcription and translation of core clock components (CLOCK, NPAS2, BMAL1, BMAL2, PER1, PER2, PER3, CRY1 and CRY2) plays a critical role in rhythm generation, whereas delays imposed by post-translational modifications (PTMs) are important for determining the period (tau) of the rhythms (tau refers to the period of a rhythm and is the length, in time, of one complete cycle). A diurnal rhythm is synchronized with the day/night cycle, while the ultradian and infradian rhythms have a period shorter and longer than 24 hours, respectively. Disruptions in the circadian rhythms contribute to the pathology of cardiovascular diseases, cancer, metabolic syndromes and aging. A transcription/translation feedback loop (TTFL) forms the core of the molecular circadian clock mechanism. Transcription factors, CLOCK or NPAS2 and BMAL1 or BMAL2, form the positive limb of the feedback loop, act in the form of a heterodimer and activate the transcription of core clock genes and clock-controlled genes (involved in key metabolic processes), harboring E-box elements (5'-CACGTG-3') within their promoters. The core clock genes: PER1/2/3 and CRY1/2 which are transcriptional repressors form the negative limb of the feedback loop and interact with the CLOCK|NPAS2-BMAL1|BMAL2 heterodimer inhibiting its activity and thereby negatively regulating their own expression. This heterodimer also activates nuclear receptors NR1D1/2 and RORA/B/G, which form a second feedback loop and which activate and repressBMAL1 transcription, respectively.BMAL1 positively regulates myogenesis and negatively regulates adipogenesis via the transcriptional control of the genes of the canonical Wnt signaling pathway. Plays a role in normal pancreatic beta-cell function; regulates glucose-stimulated insulin secretion via the regulation of antioxidant genes NFE2L2/NRF2 and its targets SESN2, PRDX3, CCLC and CCLM. Negatively regulates the mTORC1 signaling pathway; regulates the expression of MTOR and DEPTOR. Controls diurnal oscillations of Ly6C inflammatory monocytes; rhythmic recruitment of the PRC2 complex imparts diurnal variation to chemokine expression that is necessary to sustain Ly6C monocyte rhythms. Regulates the expression of HSD3B2, STAR, PTGS2, CYP11A1, CYP19A1 and LHCGR in the ovary and also the genes involved in hair growth. Plays an important role in adult hippocampal neurogenesis by regulating the timely entry of neural stem/progenitor cells (NSPCs) into the cell cycle and the number of cell divisions that take place prior to cell-cycle exit. Regulates the circadian expression of CIART and KLF11. The CLOCK-BMAL1 heterodimer regulates the circadian expression of SERPINE1/PAI1, VWF, B3, CCRN4L/NOC, NAMPT, DBP, MYOD1, PPARGC1A, PPARGC1B, SIRT1, GYS2, F7, NGFR, GNRHR, BHLHE40/DEC1, ATF4, MTA1, KLF10 and also genes implicated in glucose and lipid metabolism. Promotes rhythmic chromatin opening, regulating the DNA accessibility of other transcription factors. The NPAS2-BMAL1 heterodimer positively regulates the expression of MAOA, F7 and LDHA and modulates the circadian rhythm of daytime contrast sensitivity by regulating the rhythmic expression of adenylate cyclase type 1 (ADCY1) in the retina. The preferred binding motif for the CLOCK-BMAL1 heterodimer is 5'-CACGTGA-3', which contains a flanking adenine nucleotide at the 3-prime end of the canonical 6-nucleotide E-box sequence . CLOCK specifically binds to the half-site 5'-CAC-3', while BMAL1 binds to the half-site 5'-GTGA-3' . The CLOCK-BMAL1 heterodimer also recognizes the non-canonical E-box motifs 5'-AACGTGA-3' and 5'-CATGTGA-3' . Essential for the rhythmic interaction of CLOCK with ASS1 and plays a critical role in positively regulating CLOCK-mediated acetylation of ASS1 . Plays a role in protecting against lethal sepsis by limiting the expression of immune checkpoint protein CD274 in macrophages in a PKM2-dependent manner (By similarity). Regulates the diurnal rhythms of skeletal muscle metabolism via transcriptional activation of genes promoting triglyceride synthesis (DGAT2) and metabolic efficiency (COQ10B) (By similarity). .; FUNCTION: (Microbial infection) Regulates SARS coronavirus-2/SARS-CoV-2 entry and replication in lung epithelial cells probably through the post-transcriptional regulation of ACE2 and interferon-stimulated gene expression. . |
Accessions | ENST00000403290.6 [O00327-2] ENST00000673834.1 H0YER9 ENST00000403482.7 [O00327-7] E9PI92 O00327 E9PKN1 ENST00000674108.1 E9PSD2 ENST00000401424.6 [O00327-9] ENST00000533520.5 ENST00000530357.6 ENST00000534544.5 ENST00000524392.5 ENST00000529050.5 E9PKG7 ENST00000403510.8 [O00327-2] A0A669KBF4 E9PNI4 ENST00000529388.6 [O00327-2] ENST00000673868.1 E9PL54 A0A669KB07 ENST00000527998.5 ENST00000673888.1 E9PRB1 ENST00000529825.6 A0A669KAX2 A0A669KAV4 ENST00000389707.8 [O00327-8] ENST00000482049.6 ENST00000531665.5 ENST00000673817.1 ENST00000673892.1 ENST00000673626.1 |